TrialScientific reports2022

Microwave versus radiofrequency ablation for the treatment of liver malignancies: a randomized controlled phase 2 trial.

Aleksandar Radosevic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.